SANTOS LTD/ AU000000STO6 /
24/05/2024 08:01:42 | Chg. +0.0200 | Volume | Bid21:58:47 | Ask21:58:47 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
4.5830EUR | +0.44% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 16.51 bill.EUR | - | - |
GlobeNewswire
24/05
The Dominican Republic and Purdue University Sign MOU to Drive Semiconductor Growth
GlobeNewswire
21/05
FII Institute Unveils Top Speakers, Sessions for Inaugural Latin America Summit in June
GlobeNewswire
17/05
Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and ...
GlobeNewswire
16/05
Bioxodes receives European Patent Office intention to grant patent, offering lead asset broad protec...
GlobeNewswire
14/05
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
07/05
Hitachi Energy supports long-term operation of largest HVDC-connected wind energy project in U.S.
GlobeNewswire
07/05
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Upd...
GlobeNewswire
24/04
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progres...
GlobeNewswire
24/04
Dickey’s Barbecue in the Lineup for Dallas Cowboys Draft Party presented by Miller Lite
GlobeNewswire
24/04
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...
GlobeNewswire
23/04
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology...
GlobeNewswire
23/04
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
Newsfile Corp
18/04
Creative Heart Awakenings' Founder Announces the Launch Event of Her Book "HeART Healing for Radiant...